NO871588D0 - Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske karboksamider. - Google Patents

Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske karboksamider.

Info

Publication number
NO871588D0
NO871588D0 NO871588A NO871588A NO871588D0 NO 871588 D0 NO871588 D0 NO 871588D0 NO 871588 A NO871588 A NO 871588A NO 871588 A NO871588 A NO 871588A NO 871588 D0 NO871588 D0 NO 871588D0
Authority
NO
Norway
Prior art keywords
carboxamids
procedure
preparation
therapeutic active
active heterocyclic
Prior art date
Application number
NO871588A
Other languages
English (en)
Other versions
NO871588L (no
Inventor
Frederick Jeffrey Brown
Ying Kwong Yee
Original Assignee
Ici America Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB868609175A external-priority patent/GB8609175D0/en
Priority claimed from GB868624698A external-priority patent/GB8624698D0/en
Application filed by Ici America Inc filed Critical Ici America Inc
Publication of NO871588D0 publication Critical patent/NO871588D0/no
Publication of NO871588L publication Critical patent/NO871588L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/44—Nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/22—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an aralkyl radical attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
NO871588A 1986-04-15 1987-04-14 Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske karboksamider. NO871588L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB868609175A GB8609175D0 (en) 1986-04-15 1986-04-15 Heterocyclic carboxamides
GB868624698A GB8624698D0 (en) 1986-10-15 1986-10-15 Heterocyclic carboxamides

Publications (2)

Publication Number Publication Date
NO871588D0 true NO871588D0 (no) 1987-04-14
NO871588L NO871588L (no) 1987-10-16

Family

ID=26290629

Family Applications (1)

Application Number Title Priority Date Filing Date
NO871588A NO871588L (no) 1986-04-15 1987-04-14 Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske karboksamider.

Country Status (20)

Country Link
EP (1) EP0242167B1 (no)
JP (1) JPH0768211B2 (no)
KR (1) KR870010010A (no)
CN (1) CN87103504A (no)
AU (1) AU602515B2 (no)
DE (1) DE3774749D1 (no)
DK (1) DK190587A (no)
ES (1) ES2038172T3 (no)
FI (1) FI871632A (no)
GB (1) GB8707051D0 (no)
GR (1) GR3003209T3 (no)
HU (1) HU199791B (no)
IE (1) IE60013B1 (no)
IL (1) IL82126A0 (no)
NO (1) NO871588L (no)
NZ (1) NZ219978A (no)
PL (1) PL153341B1 (no)
PT (1) PT84681B (no)
SU (1) SU1597098A3 (no)
ZW (1) ZW6387A1 (no)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3650567T2 (de) * 1985-10-17 1997-02-20 Zeneca Inc Medizinische Indol- und Indazol-Ketosulfonderivate
MY103259A (en) * 1987-04-15 1993-05-29 Ici America Inc Aliphatic carboxamides
US5281593A (en) * 1990-07-31 1994-01-25 Lilly Industries Limited Certain indole derivatives useful as leukotriene antagonists
US5095031A (en) * 1990-08-20 1992-03-10 Abbott Laboratories Indole derivatives which inhibit leukotriene biosynthesis
GB9020338D0 (en) * 1990-09-18 1990-10-31 Lilly Industries Ltd Pharmaceutical compounds
SK281737B6 (sk) * 1996-04-19 2001-07-10 American Home Products Corporation 2-fenylindolové zlúčeniny, farmaceutický prostriedok s ich obsahom a ich použitie
AP1147A (en) * 1996-05-03 2003-02-25 Pfizer Substituted indazole derivatives and related compounds.
SK176598A3 (en) * 1996-06-25 2000-06-12 Pfizer Indazole derivatives, pharmaceutical composition on their base and methods of treatment
US6069153A (en) * 1998-05-12 2000-05-30 American Home Products Corporation Indenoindoles and benzocarbazoles as estrogenic agents
US6479535B1 (en) 1998-05-15 2002-11-12 Wyeth 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole and estrogen formulations
US6159959A (en) * 1999-05-06 2000-12-12 American Home Products Corporation Combined estrogen and antiestrogen therapy
EP2335700A1 (en) 2001-07-25 2011-06-22 Boehringer Ingelheim (Canada) Ltd. Hepatitis C virus polymerase inhibitors with a heterobicylic structure
US7098231B2 (en) 2003-01-22 2006-08-29 Boehringer Ingelheim International Gmbh Viral polymerase inhibitors
US7223785B2 (en) 2003-01-22 2007-05-29 Boehringer Ingelheim International Gmbh Viral polymerase inhibitors
US7582770B2 (en) 2004-02-20 2009-09-01 Boehringer Ingelheim International Gmbh Viral polymerase inhibitors
EP1915378A4 (en) 2005-08-12 2009-07-22 Boehringer Ingelheim Int VIRUS POLYMERASE INHIBITORS
KR20080047591A (ko) * 2005-09-07 2008-05-29 플렉시콘, 인코퍼레이티드 Ｐｐａｒ 조절인자로서 사용하기 위한 1,3-이치환된 인돌유도체
CN101130515B (zh) * 2006-08-24 2011-06-15 中国科学院上海药物研究所 取代-1h-吲哚类化合物、其制备方法、其应用及其药物组合物
JP5640086B2 (ja) * 2009-08-03 2014-12-10 アジェンデ・キミケ・リウニテ・アンジェリニ・フランチェスコ・ア・チ・エレ・ア・エフェ・ソシエタ・ペル・アチオニＡｚｉｅｎｄｅ Ｃｈｉｍｉｃｈｅ Ｒｉｕｎｉｔｅ Ａｎｇｅｌｉｎｉ Ｆｒａｎｃｅｓｃｏ Ａ．Ｃ．Ｒ．Ａ．Ｆ．Ｓｏｃｉｅｔａ Ｐｅｒ Ａｚｉｏｎｉ １−ベンジル−３−ヒドロキシメチル−１ｈ−インダゾール及びその誘導体の製造方法並びに必要なマグネシウム中間体
CN105884662B (zh) * 2016-06-14 2017-07-21 岳阳蓬诚科技发展有限公司 一种二甲基砜的生产工艺
CN105837477B (zh) * 2016-06-14 2017-07-21 岳阳蓬诚科技发展有限公司 一种二甲基砜的制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE738727C (de) * 1942-07-11 1943-08-30 August Engels G M B H Vorrichtung zum Entleeren von Formkaesten
US3271416A (en) * 1961-10-24 1966-09-06 Merck & Co Inc Indolyl aliphatic acids
FR4035M (no) * 1964-11-04 1966-03-28
FR7631M (no) * 1968-08-13 1970-01-26
US3470298A (en) * 1969-01-29 1969-09-30 Acraf Topical anti-inflammatory composition containing (indazole-3-yl)-oxyalkanoic acids
US4436746A (en) * 1982-09-30 1984-03-13 Ciba-Geigy Corporation Thromboxane synthetase inhibitory N-substituted-2-(1-imidazolyl)indoles
CA1241660A (en) * 1984-06-25 1988-09-06 Yvan Guindon Indole-2-alkanoic acids
GB8524157D0 (en) * 1984-10-19 1985-11-06 Ici America Inc Heterocyclic amides

Also Published As

Publication number Publication date
IE60013B1 (en) 1994-05-18
DK190587A (da) 1987-10-16
JPS638369A (ja) 1988-01-14
JPH0768211B2 (ja) 1995-07-26
ES2038172T3 (es) 1993-07-16
GR3003209T3 (en) 1993-02-17
KR870010010A (ko) 1987-11-30
AU602515B2 (en) 1990-10-18
FI871632A0 (fi) 1987-04-14
EP0242167B1 (en) 1991-11-27
PL265151A1 (en) 1989-03-06
PL153341B1 (en) 1991-04-30
IL82126A0 (en) 1987-10-30
CN87103504A (zh) 1987-12-09
IE870837L (en) 1987-10-15
HU199791B (en) 1990-03-28
DE3774749D1 (de) 1992-01-09
EP0242167A3 (en) 1988-10-12
NO871588L (no) 1987-10-16
NZ219978A (en) 1990-08-28
AU7139387A (en) 1987-10-22
HUT43819A (en) 1987-12-28
FI871632A (fi) 1987-10-16
SU1597098A3 (ru) 1990-09-30
ZW6387A1 (en) 1988-11-23
EP0242167A2 (en) 1987-10-21
PT84681B (pt) 1989-12-29
PT84681A (en) 1987-05-01
GB8707051D0 (en) 1987-04-29
DK190587D0 (da) 1987-04-13

Similar Documents

Publication Publication Date Title
NO871266D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinazolin-derivater.
NO871267L (no) Fremgangsmaate for fremstilling av terapeutisk aktive tiazepinforbindelser.
NO895086L (no) Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske forbindelser.
NO883974L (no) Fremgangsmaate for fremstilling av terapeutiske aktive tetrahydro-hydroksypyranon-derivater.
NO871277D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive oxadiazoler.
NO853293L (no) Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske derivater.
NO870526D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive dikloranilin-derivater.
NO870075L (no) Fremgangsmaate for fremstilling av terapeutisk aktive indol-derivater.
NO864126D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyridon-derivater.
NO874869L (no) Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser.
NO884473D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive imidazoler.
NO874032L (no) Fremgangsmaate for fremstilling av terapeutisk aktive catecholderivater.
NO871588L (no) Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske karboksamider.
NO883485D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive piperidinyl-isokinolinforbindelser.
NO875488D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive alkansulfonanilid-derivater.
NO871044L (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyrimidinderivater.
NO880667D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive arylpiperazinyl-alkylen-fenyl-heterocykliske forbindelser.
NO862372D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater.
NO884175L (no) Fremgangsmaate for fremstilling av terapeutiske aktive heterocykliske derivater.
NO167802C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzotiazepinderivater.
NO864101L (no) Fremgangsmaate for fremstilling av terapeutisk aktive dikloranilinderivater.
NO168247C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-metoksy-alkyl-ammonium-tetrahydrofuraner.
NO871907D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive alkenamid-derivater.
NO882281D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyrazinamider.
NO883959L (no) Fremgangsmaate for fremstilling av terapeutisk aktive fenolestere.